These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 31072394)
1. Patients' high acceptability of a future therapeutic HIV vaccine in France: a French paradox? Dimi S; Zucman D; Chassany O; Lalanne C; Prazuck T; Mortier E; Majerholc C; Aubin-Auger I; Verger P; Duracinsky M BMC Infect Dis; 2019 May; 19(1):401. PubMed ID: 31072394 [TBL] [Abstract][Full Text] [Related]
2. Perception of immunizations and vaccine recommendation sources for persons living with HIV compared with persons without HIV. Mills AR; Arnett SJ; Shan M; Simmons C; Miller ML J Am Pharm Assoc (2003); 2019; 59(4S):S39-S46. PubMed ID: 31248848 [TBL] [Abstract][Full Text] [Related]
3. Vaccine characteristics and acceptability of HIV immunization among adolescents. Zimet GD; Blythe MJ; Fortenberry JD Int J STD AIDS; 2000 Mar; 11(3):143-9. PubMed ID: 10726935 [TBL] [Abstract][Full Text] [Related]
4. Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa. Chimoyi L; Kamndaya M; Venables E; von Knorring N; Stadler J; MacPhail C; Chersich MF; Rees H; Delany-Moretlwe S BMC Public Health; 2017 Jul; 17(Suppl 3):524. PubMed ID: 28832280 [TBL] [Abstract][Full Text] [Related]
5. "Sisters, Mothers, Daughters and Aunties": HIV vaccine acceptability among African, Caribbean and other Black women in Toronto. Weaver J; Newman PA; Williams CC; Massaquoi N; Brown M Can J Public Health; 2013 Aug; 104(5):e413-7. PubMed ID: 24183184 [TBL] [Abstract][Full Text] [Related]
6. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. Starace F; Wagner TM; Luzi AM; Cafaro L; Gallo P; Rezza G AIDS Care; 2006 Jan; 18(1):66-72. PubMed ID: 16282079 [TBL] [Abstract][Full Text] [Related]
7. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand. Newman PA; Roungprakhon S; Tepjan S; Yim S Vaccine; 2010 Jan; 28(4):958-64. PubMed ID: 19925897 [TBL] [Abstract][Full Text] [Related]
8. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics. Newman PA; Duan N; Lee SJ; Rudy ET; Seiden DS; Kakinami L; Cunningham WE Vaccine; 2006 Mar; 24(12):2094-101. PubMed ID: 16332402 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda. Muhindo R; Okoboi S; Kiragga A; King R; Arinaitwe WJ; Castelnuovo B PLoS One; 2022; 17(12):e0278692. PubMed ID: 36459514 [TBL] [Abstract][Full Text] [Related]
10. Differences in HIV vaccine acceptability between genders. Kakinami L; Newman PA; Lee SJ; Duan N AIDS Care; 2008 May; 20(5):542-6. PubMed ID: 18484322 [TBL] [Abstract][Full Text] [Related]
11. An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria. Njoku OS; Manak MM; O'Connell RJ; Shutt AL; Malia JA; Heipertz RA; Tovanabutra S; Milazzo MJ; Akintunde GA; Alabi AS; Suleiman A; Ogundeji AA; Kene TS; Nelson R; Ayemoba OR; Singer DE; Robb ML; Peel SA; Michael NL PLoS One; 2016; 11(12):e0166711. PubMed ID: 27936236 [TBL] [Abstract][Full Text] [Related]
12. HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study. Young AM; DiClemente RJ; Halgin DS; Sterk CE; Havens JR BMC Public Health; 2014 May; 14():537. PubMed ID: 24885970 [TBL] [Abstract][Full Text] [Related]
13. The acceptability of HIV immunization: examining vaccine characteristics as determining factors. Liau A; Zimet GD AIDS Care; 2001 Oct; 13(5):643-50. PubMed ID: 11571011 [TBL] [Abstract][Full Text] [Related]
14. Acceptability of vaccination against HIV: A mapping of Togolese people's positions. Kpanake L; Gbandey S; Sorum PC; Mullet E J Health Psychol; 2018 May; 23(6):800-806. PubMed ID: 27611628 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. Suhadev M; Nyamathi AM; Swaminathan S; Suresh A; Venkatesan P AIDS Res Hum Retroviruses; 2009 Feb; 25(2):217-24. PubMed ID: 19239362 [TBL] [Abstract][Full Text] [Related]
16. HIV vaccine acceptability: a systematic review and meta-analysis. Newman PA; Logie C AIDS; 2010 Jul; 24(11):1749-56. PubMed ID: 20597165 [TBL] [Abstract][Full Text] [Related]
17. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials. Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748 [TBL] [Abstract][Full Text] [Related]
18. HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach. Lee SJ; Brooks RA; Newman PA; Seiden D; Sangthong R; Duan N AIDS Care; 2008 Nov; 20(10):1161-8. PubMed ID: 18608068 [TBL] [Abstract][Full Text] [Related]
19. A cross sectional survey of the barriers for implementing rapid HIV testing among French general practitioners. Fraisse T; Fourcade C; Brazes-Sanz J; Koumar Y; Lavigne JP; Sotto A; Laureillard D Int J STD AIDS; 2016 Oct; 27(11):1005-12. PubMed ID: 26429893 [TBL] [Abstract][Full Text] [Related]
20. Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada. Fleming T; Valleriani J; Ng C; Maher L; Small W; McNeil R BMC Public Health; 2020 Jul; 20(1):1081. PubMed ID: 32646390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]